Age- and genotype-related neurophysiologic reactivity to oxidative stress in healthy adults

Neurobiology of Aging

Volumn 33, Issue 4, 2012, Pages 839.e11-839.e21

  Ponomareva, Natalya V ^a   Goltsov, Andrey Y ^c   Kunijeva, Svetlana S ^b,c   Scheglova, Nadejda S ^a   Malina, Daria D ^a   Mitrofanov, Andrey A ^d   Boikova, Tatiana I ^b   Rogaev, Evgeny I ^e  

^a RESEARCH CENTER OF NEUROLOGY   (Russian Federation)

^b MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

^c VAVILOV INSTITUTE OF GENERAL GENETICS   (Russian Federation)

^d Research Institute of Psychiatry   (Russian Federation)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Aging; Alzheimer's disease; Apolipoprotein E; Cerebrovascular disease; EEG; Hyperventilation; Hypocapnia; Oxidative stress

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON4; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; AGING; ALPHA RHYTHM; APOE GENE; ARTICLE; BETA RHYTHM; DELTA RHYTHM; ELECTROENCEPHALOGRAM; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; HYPERVENTILATION; MALE; NEUROPHYSIOLOGY; NORMAL HUMAN; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; THETA RHYTHM;

EID: 84856972002     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.11.013     Document Type: Article

References (61)

1. Arai T., Ikeda K., Akiyama H., Haga C., Usami M., Sahara N., Iritani S., Mori H. A high incidence of apolipoprotein E epsilon4 allele in middle-aged non-demented subjects with cerebral amyloid beta protein deposits. Acta Neuropathol 1999, 97:82-84.
2. Babiloni C., Benussi L., Binetti G., Cassetta E., Dal Forno G., Del Percio C., Ferreri F., Ferri R., Frisoni G., Ghidoni R., Miniussi C., Rodriguez G., Romani G.L., Squitti R., Ventriglia M.C., Rossini P.M. Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: a multicentric electroencephalogram study. Ann Neurol 2006, 59:323-334.
3. Battaglia M. Beyond the usual suspects: a cholinergic route for panic attacks. Mol Psychiatry 2002, 7:239-246.
4. Beal M.F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?. Ann. Neurol 1992, 31:119-130.
5. Beisiengel U., Arlt S., Daher D., Schippling S., Mann U., Muller-Thomsen T., Sturenburg H.-J., Buhmann C., Bernhardt R., Mann W.A., Kontush A. Apolipoprotein E genotype determines the lipid level in and oxidizability of human cerebrospinal fluid. Soc. Neurosci. Abstr 1997, 23:1834.
6. Borinskaia S., Kal'ina N., Sanina E., Kozhekbaeva Zh., Gupalo E., Garmash I., Ogurtsov P., Parshukova O., Boǐko S., Veselovskiǐ E., Vershubskaia G., Kozlov A., Rogaev E., Iankovskiǐ N. Polymorphism of the apolipoprotein E gene (APOE) in the populations of Russia and neighboring countries [in Russian]. Genetica 2007, 43:1434-1440.
7. Braak H., Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 1997, 18:351-357.
8. Chesler M., Kaila K. Modulation of pH by neuronal activity. Trends Neurosci 1992, 15:396-402.
9. Cohen R.M., Carson R.E., Filbey F., Szczepanik J., Sunderland T. Age and APOE-epsilon4 genotype influence the effect of physostigmine infusion on the in-vivo distribution volume of the muscarinic-2-receptor dependent tracer [18F]FP-TZTP. Synapse 2006, 60:86-92.
10. Dager S.R., Strauss W.L., Marro K.I., Richards T.L., Metzger G.D., Artru A.A. Proton magnetic resonance spectroscopy investigation of hyperventilation in subjects with panic disorder and comparison subjects. Am. J. Psychiatry 1995, 152:666-672.
11. Daulatzai M.A. Early stages of pathogenesis in memory impairment during normal senescence and Alzheimer's disease. J. Alzheimers Dis 2010, 20:355-367.
12. Dean J.B., Mulkey D.K., Henderson R.A., Potter S.J., Putnam R.W. Hyperoxia, reactive oxygen species, and hyperventilation: oxygen sensitivity of brain stem neurons. J. Appl. Physiol 2004, 96:784-791.
13. Eckelman W.C. Imaging of muscarinic receptors in the central nervous system. Curr. Pharm. Des 2006, 12:3901-3913.
14. Eichner J.E., Dunn S.T., Perveen G., Thompson D.M., Stewart K.E., Stroehla B.C. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am. J. Epidemiol 2002, 155:487-495.
15. Ertekin-Taner N. Genetics of Alzheimer's disease: a centennial review. Neurol. Clin 2007, 25:611-667.
16. Farrer L.A., Cupples A., Haines J.L., Kukul B., Hyman l.W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer's disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997, 278:1349-1356.
17. Filbey F.M., Slack K.J., Sunderland T.P., Cohen R.M. Functional magnetic resonance imaging and magnetoencephalography differences associated with APOEepsilon4 in young healthy adults. Neuroreport 2006, 17:1585-1590.
18. Filippini N., Ebmeier K.P., MacIntosh B.J., Trachtenberg A.J., Frisoni G.B., Wilcock G.K., Beckmann C.F., Smith S.M., Matthews P.M., Mackay C.E. Differential effects of the APOE genotype on brain function across the lifespan. Neuroimage 2011, 54:602-610.
19. Fokin V.F., Ponomareva N.V., Orlov O.N., Lideman R.R., Erin A.N. Relations between electricity reactions of the brain and lipid peroxidation in patients with pathological aging [in Russian]. Bull. Exp. Biol. Med 1989, 54:682-684.
20. Ghebremedhin E., Schultz C., Braak E., Braak H. High frequency of apolipoprotein E ε4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes. Exp. Neurol 1998, 153:152-155.
21. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R., Newton P., Rooke K., Roques P., Talbot C., Pericak-Vance M., Roses A., Williamson R., Rossor M., Owen M., Hardy J. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991, 349:704-706.
22. Gullapalli D., Fountain N.B. Clinical correlation of occipital intermittent rhythmic delta activity. J. Clin. Neurophysiol 2003, 20:35-41.
23. Hughes C., Berg L., Danziger W., Coben L., Martin R. A new clinical scale for the staging of dementia. Br. J. Psychiatry 1982, 140:566-572.
24. Illarioshkin, S., 2003. Conformational Brain Diseases [in Russian]. Yanus, Moscow.
25. Jelic V., Julin P., Shigeta M., Nordberg A., Lannfelt L., Winblad B., Wahlund L.-O. Apolipoprotein E epsilon 4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence. J. Neurol. Neurosurg. Psychiatry 1997, 63:59-65.
26. Jibiki I., Kurokawa K., Matsuda H., Fukushima T., Yamaguchi N., Hisada K. Widespread reduction of regional cerebral blood flow during hyperventilation-induced EEG slowing ("buildup"). Observation from subtraction of brain imaging with single photon emission computed tomography using technetium-99m hexamethyl-propyleneamine oxime. Neuropsychobiology 1992, 26:120-124.
27. Kadotani H., Kadotani T., Young T., Peppard P.E., Finn L., Colrain I.M., Murphy G.M., Mignot E. Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults. JAMA 2001, 285:2888-2890.
28. Kennealy J.A., Penovich P.E., Moore-Nease S.E. EEG and Spectral analysis in acute hyperventilation. Electroencephalogr. Clin. Neurophysiol 1986, 63:98-106.
29. Korovaitseva G.I., Bukina A., Farrer L.A., Rogaev E.I. Presenilin polymorphisms in Alzheimer's disease. Lancet 1997, 350:959.
30. LaFerla F.M. The Alzheimer's beta-amyloid peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Behav. Pharmacol. 1995, 6(suppl):55.
31. Lavi S., Gaitini D., Milloul V., Jacob G. Impaired cerebral CO2 vasoreactivity: association with endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol 2006, 291:1856-1861.
32. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., Wang K. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995, 269:973-977.
33. Mäkiranta M.J., Ruohonen J., Suominen K., Sonkajärvi E., Salomäki T., Kiviniemi V., Seppänen T., Alahuhta S., Jäntti V., Tervonen O. BOLD-contrast functional MRI signal changes related to intermittent rhythmic delta activity in EEG during voluntary hyperventilation-simultaneous EEG and fMRI study. Neuroimage 2004, 22:222-231.
34. Millhorn D.E., Eldridge F.L. Role of ventrolateral medulla in regulation of respiratory and cardiovascular systems. J. Appl. Physiol 1986, 61:1249-1263.
35. Nattie E. CO2, brainstem chemoreceptors and breathing. Prog. Neurobiol 1999, 59:299-331.
36. Palop J.J., Chin J., Roberson E.D., Wang J., Thwin M.T., Bien-Ly N., Yoo J., Ho K.O., Yu G.Q., Kreitzer A., Finkbeiner S., Noebels J.L., Mucke L. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 2007, 55:697-711.
37. Palop J.J., Mucke L. Epilepsy and cognitive impairments in Alzheimer disease. Arch. Neurol 2009, 66:435-440.
38. Ponomareva N.V., Korovaitseva G.I., Rogaev E.I. EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease. Neurobiol. Aging 2008, 29:819-827.
39. Ponomareva N.V., Selesneva N.D., Jarikov G.A. EEG alterations in subjects at high familial risk for Alzheimer's disease. Neuropsychobiology 2003, 48:152-159.
40. Prichep L.S., John E.R., Ferris S.H., Rausch L., Fang Z., Cancro R., Torossian C., Reisberg B. Prediction of longitudinal cognitive decline in normal elderly with subjective complaints using electrophysiological imaging. Neurobiol. Aging 2006, 27:471-481.
41. Qiu Z., Crutcher K.A., Hyman B.T., Rebeck G.W. ApoE isoforms affect neuronal N-methyl-D-aspartate calcium responses and toxicity via receptor-mediated processes. Neuroscience 2003, 122:291-303.
42. Reiman E.M., Chen K., Alexander G.E., Caselli R.J., Bandy D., Osborne D., Saunders A.M., Hardy J. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:284-289.
43. Rogaev E.I. Genetic factors and a polygenic model of Alzheimer's disease [in Russian]. Genetika 1999, 35:1558-1571.
44. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., Mar L., Sorbi S., Nacmias B., Piacentini S., Amaducci L., Chumakov L., Cohen D., Lannfeldt L., Fraser P.E., Rommens J.M., St.George-Hyslop P.H. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995, 376:775-778.
45. Sacre S.M., Stannard A.K., Owen J.S. Apolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cells. FEBS Lett 2003, 540:181-187.
46. Saunders A.M., Strittmatter W.J., Schmechel D., St.George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., Roses A. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993, 43:1467-1472.
47. Schmechel D.E., Saunders A.M., Strittmatter W.J., Crain B.J., Hulette C.M., Joo S.H., Pericak-Vance M.A., Goldgaber D., Roses A.D. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:9649-9653.
48. Schneider J.A., Bienias J.L., Wilson R.S., Berry-Kravis E., Evans D.A., Bennett D.A. The apolipoprotein E epsilon4 allele increases the odds of chronic cerebral infarction [corrected] detected at autopsy in older persons. Stroke 2005, 36:954-959.
49. Shah K., Qureshi S.U., Johnson M., Parikh N., Schulz P.E., Kunik M.E. Does use of antihypertensive drugs affect the incidence or progression of dementia?. A systematic review. Am. J. Geriatr. Pharmacother 2009, 7:250-261.
50. Shao X.M., Feldman J.L. Central cholinergic regulation of respiration: nicotinic receptors. Acta Pharmacol. Sin 2009, 30:761-770.
51. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.F., Bruni A.C., Montesi M.P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R.J., Wasco W., Da Silva H.A., Haines J.L., Perkicak-Vance M.A., Tanzi R.E., Roses A.D., Fraser P.E., Rommens J.M., St George-Hyslop P.H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995, 375:754-760.
52. Silvestrini M., Pasqualetti P., Baruffaldi R., Bartolini M., Handouk Y., Matteis M., Moffa F., Provinciali L., Vernieri F. Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease. Stroke 2006, 37:1010-1015.
53. Sparing R., Dafotakis M., Buelte D., Meister I.G., Noth J. Excitability of human motor and visual cortex before, during, and after hyperventilation. J. Appl. Physiol 2007, 102:406-411.
54. Steriade M., Gloor P., Lopes da Silva R., Llinas F., Mesulam M. Basic mechanisms of cerebral rhythmic activities. Electroenceph. Clin. Neurophysiol 1990, 76:481-508.
55. Van der Hiele K., Bollen E.L., Vein A.A., Reijntjes R.H., Westendorp R.G., van Buchem M.A., Middelkoop H.A., van Dijk J.G. EEG markers of future cognitive performance in the elderly. J. Clin. Neurophysiol 2008, 25:83-89.
56. Van der Worp H.B., Kraaier V., Wieneke G.H., Van Huffelen A.C. Quantitative EEG during progressive hypocarbia and hypoxia. Hyperventilation-induced EEG changes reconsidered. Electroencephalogr. Clin. Neurophysiol 1991, 79:335-341.
57. Versavel M., Leonard J.P., Herrmann W.M. Standard operating procedure for the registration and computer-supported evaluation of pharmaco-EEG data. 'EEG in Phase I' of the Collegium Internationale Psychiatriae Scalarum (CIPS). Neuropsychobiology 1995, 32:166-170.
58. Veselá A., Wilhelm J. The role of carbon dioxide in free radical reactions of the organism. Physiol. Res 2002, 51:335-339.
59. Wei W., Nguyen L.N., Kessels H.W., Hagiwara H., Sisodia S., Malinow R. Amyloid beta from axons and dendrites reduces local spine number and plasticity. Nat. Neurosci 2010, 13:190-196.
60. Xie A., Skatrud J.B., Morgan B., Chenuel B., Khayat R., Reichmuth K., Lin J., Dempsey J.A. Influence of cerebrovascular function on the hypercapnic ventilatory response in healthy humans. J. Physiol 2006, 577:319-329.
61. Zenkov, L.R., 2002. Clinical Epileptologia [in Russian]. MIA, Moscow.